Study Summary
This trial is designed to see if PGx testing can help reduce polypharmacy (use of multiple medications) among Veterans with mental illness.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 1 Secondary · Reporting Duration: 12 weeks
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Delayed return of results
1 of 2
Immediate return of results
1 of 2
Active Control
Experimental Treatment
500 Total Participants · 2 Treatment Groups
Primary Treatment: Pharmacogenetic test · No Placebo Group · Phase 4
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 80 · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| Maryland | 66.7% |
| Pennsylvania | 33.3% |
How old are they?
| 65+ | 100.0% |
What site did they apply to?
| Cpl Michael J Crescenz VAMC | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
Why did patients apply to this trial?
- "I want to try different things to help my mental disorder"
How many prior treatments have patients received?
| 1 | 100.0% |
Frequently Asked Questions
Does this trial accept participants aged 85 or older?
"This study is open to those within the 18-80 age range." - Anonymous Online Contributor
How many participants are currently enrolled in this research study?
"Affirmative. The information posted on clinicaltrials.gov testifies that this medical trial is presently in search of participants. It was first advertised on June 2nd, 2020 and the last update came through July 6th 2021 with a demand for 500 patients to be recruited from one site." - Anonymous Online Contributor
Are there any openings for participants in this medical research?
"Confirming the details on clinicaltrials.gov, this medicinal experiment is still recruiting patients. It was initially released to the public on June 2nd 2020 and has been modified as recenty as July 6th 2021." - Anonymous Online Contributor
To whom is the opportunity to participate in this experiment available?
"To apply for this medical research, potential participants must have a psychiatric or mood-related disorder and be aged between 18 to 80. To date, approximately 500 individuals have been accepted into the study." - Anonymous Online Contributor
Has the FDA authorized Pharmacogenetic testing?
"The safety of pharmacogenetic testing has been well established, so it was awarded a score of 3." - Anonymous Online Contributor